Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS Patients
Completed · Phase 4
Conditions studied: Multiple Sclerosis
In brief
The purpose of this study is to evaluate the feasibility of \[18F\]Florbetapir positron emission tomography (PET) for assessment of demyelination in the patients with relapsing remitting multiple sclerosis.
Key facts
- Study ID
- NCT01767493
- Run by
- Institute for Neurodegenerative Disorders
- People needed
- 19
- Starts
- 2012-11-01
- Expected to finish
- 2013-11-01
- Last updated by the study team
- 2021-08-30
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.
Where it is running
- Institute for Neurodegenerative Disorders — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.